Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATRA Atara Biotherapeutics

休市中 08-16 16:00:00 EDT

7.01

+0.18

+2.64%

盘后7.01

+0.000.00%

19:39 EDT

最高7.13	最低6.50	成交量12.55万
今开7.01	昨收6.83	日振幅9.22%
总市值3,445万	流通市值2,398万	总股本491.50万
成交额84.34万	换手率3.67%	流通股本342.04万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":7.01,"timestamp":1723838400000,"preClose":6.83,"halted":0,"volume":125488,"hourTrading":{"tag":"盘后","latestPrice":7.01,"preClose":7.01,"latestTime":"19:39 EDT","volume":435,"amount":2978.73,"timestamp":1723851596454},"delay":0,"floatShares":3420432,"shares":4915049,"eps":-35.58697,"marketStatus":"休市中","marketStatusCode":7,"change":0.18,"latestTime":"08-16 16:00:00 EDT","open":7.01,"high":7.13,"low":6.5,"amount":843367.954528,"amplitude":0.09224,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-35.58697,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1413432000000,"adjPreClose":6.83,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.01,"preClose":6.83,"latestTime":"09:24 EDT","volume":3831,"amount":26774.1514143,"timestamp":1723814672804},"postHourTrading":{"tag":"盘后","latestPrice":7.01,"preClose":7.01,"latestTime":"19:39 EDT","volume":435,"amount":2978.73,"timestamp":1723851596454},"volumeRatio":2.172538567092036,"impliedVol":0.0156,"impliedVolPercentile":0.0047},"requestUrl":"/m/hq/s/ATRA","defaultTab":"news","newsList":[{"id":"2459479762","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459479762","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459479762?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:04","pubTimestamp":1723734259,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时04分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅下挫5.44%。截至发稿，该股报7.30美元/股，成交量3.0311万股，换手率0.62%，振幅8.42%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6316.39%、2040.88%、570.93%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523042098e350e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523042098e350e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2459481487","title":"Atara Biotherapeutics, Inc.盘中异动 快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459481487","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459481487?lang=zh_cn&edition=full","pubTime":"2024-08-15 04:01","pubTimestamp":1723665669,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日04时01分，Atara Biotherapeutics, Inc.股票出现异动，股价急速下跌5.11%。截至发稿，该股报7.61美元/股，成交量3.5345万股，换手率0.72%，振幅8.73%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Unicycive Therapeutics, Inc.、Virax Biolabs Group Limited涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Genprex, Inc.较为活跃，换手率分别为166.90%、165.08%、98.13%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Virax Biolabs Group Limited，振幅分别为60.83%、58.52%、55.38%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815040110af9765c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815040110af9765c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2459813401","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459813401","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459813401?lang=zh_cn&edition=full","pubTime":"2024-08-14 03:58","pubTimestamp":1723579107,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日03时58分，Atara Biotherapeutics, Inc.股票出现波动，股价急速上涨6.05%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。其相关个股中，Prelude Therapeutics Incorporated、Orgenesis Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为155.27%、143.27%、43.86%，振幅较大的相关个股有冠科美博、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Zura Bio Limited C/Wts ，振幅分别为85.91%、64.05%、59.26%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035827968260e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035827968260e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2459189884","title":"Atara Biotherapeutics, Inc.2024财年第二财季实现净利润-19.05百万美元，同比增加73.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459189884","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459189884?lang=zh_cn&edition=full","pubTime":"2024-08-14 00:00","pubTimestamp":1723564825,"startTime":"0","endTime":"0","summary":"8月14日，Atara Biotherapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-19.05百万美元，同比增加73.21%；其中营业收入为28.64百万美元，同比增加2892.69%，每股基本收益为-3.10美元。从资产负债表来看，Atara Biotherapeutics, Inc.总负债2.28亿美元，其中短期债务14.68百万美元，资产负债比为0.52，流动比率为42.17。机构评级：截至2024年8月14日，当前有4家机构对Atara Biotherapeutics, Inc.目标价做出预测，其中目标均价为26.00美元，其中最低目标价为11.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140000319f27dffd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140000319f27dffd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA"],"gpt_icon":0},{"id":"2459999627","title":"Atara Biotherapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459999627","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459999627?lang=zh_cn&edition=full","pubTime":"2024-08-13 09:40","pubTimestamp":1723513208,"startTime":"0","endTime":"0","summary":"   * Atara Biotherapeutics Inc   报告，截至6月底的季度调整后每股亏损3.10美元，高于去年同期的每股亏损17.00美元。五位分析师对该季度的平均预期是每股亏损 1.56 美元。华尔街预期为每股亏损 4.50 美元至 1.50 美元。* Atara Biotherapeutics Inc公布的本季度每股收益为亏损3.10美元。* Atara Biotherapeutics Inc本季度股价下跌了10.8%，今年迄今为止亏损了40.9%。华尔街对 Atara Biotherapeutics Inc 的 12 个月目标价中位数为 40.00 美元。本摘要由 LSEG 数据于世界协调时 8 月 13 日凌晨 01:39 自动生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Atara Biotherapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2456282284","title":"Atara Biotherapeutics Inc   预计每股亏损1.56美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456282284","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456282284?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:00","pubTimestamp":1722607202,"startTime":"0","endTime":"0","summary":"   * Atara Biotherapeutics Inc    将于8月6日公布截至2001年1月1日的季度业绩(估计)，预计该公司的季度收入将有所增长。* LSEG 的分析师平均预计 Atara Biotherapeutics Inc 每股亏损 1.56 美元。* 华尔街对 Atara Biotherapeutics Inc 的 12 个月目标价中位数为 40.00 美元，高于其上次收盘价 10.40 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Atara Biotherapeutics Inc   预计每股亏损1.56美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA"],"gpt_icon":0},{"id":"2456287213","title":"Atara Biotherapeutics, Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456287213","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456287213?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:35","pubTimestamp":1722605721,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时35分，Atara Biotherapeutics, Inc.股票出现波动，股价快速下跌5.00%。截至发稿，该股报9.88美元/股，成交量1006股，换手率0.02%，振幅0.10%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为376.23%、183.09%、22.23%，振幅较大的相关个股有Exicure, Inc.、Dermata Therapeutics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为33.34%、31.45%、17.87%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213521aefcf8cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213521aefcf8cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2456043368","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456043368","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456043368?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:30","pubTimestamp":1722519056,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时30分，Atara Biotherapeutics, Inc.股票出现波动，股价快速上涨5.09%。截至发稿，该股报10.33美元/股，成交量1334股，换手率0.03%，振幅0.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Immuneering Corporation、Entera Bio Ltd.、Renovaro Inc.涨幅较大，Immuneering Corporation、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.较为活跃，换手率分别为43.07%、36.99%、13.21%，振幅较大的相关个股有Proqr Therapeutics N.V.、Biomea Fusion, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为9.33%、7.09%、5.52%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080121305796822af6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080121305796822af6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2456516547","title":"Atara Biotherapeutics, Inc.盘中异动 急速拉升5.82%报10.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456516547","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456516547?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:19","pubTimestamp":1722449978,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日02时19分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅上涨5.82%。截至发稿，该股报10.19美元/股，成交量1.7084万股，换手率0.35%，振幅7.50%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Molecular Partners Ag、Alpha Tau Medical Ltd C/Wts 、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为688.33%、167.75%、147.35%，振幅较大的相关个股有Renovaro Inc.、Alpha Tau Medical Ltd C/Wts 、Cns Pharmaceuticals, Inc.，振幅分别为79.10%、52.94%、52.15%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080102193996822572&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080102193996822572&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2455638869","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455638869","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455638869?lang=zh_cn&edition=full","pubTime":"2024-07-31 00:57","pubTimestamp":1722358640,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日00时57分，Atara Biotherapeutics, Inc.股票出现异动，股价快速跳水5.19%。截至发稿，该股报9.86美元/股，成交量8800股，换手率0.18%，振幅6.01%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Imunon, Inc.、Celularity Inc C/Wts 16/07/2026 、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为1904.17%、1499.76%、1247.79%，振幅较大的相关个股有Imunon, Inc.、Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.，振幅分别为78.15%、59.59%、55.88%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731005720941fbf91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731005720941fbf91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2455466614","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455466614","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455466614?lang=zh_cn&edition=full","pubTime":"2024-07-29 22:13","pubTimestamp":1722262400,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日22时13分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅上涨6.49%。截至发稿，该股报10.83美元/股，成交量7088股，换手率0.14%，振幅7.08%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大，Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为1713.60%、191.10%、156.77%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为118.78%、75.11%、57.78%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729221320aefbfb44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729221320aefbfb44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2453688303","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.01%报9.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453688303","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453688303?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:03","pubTimestamp":1721829818,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时03分，Atara Biotherapeutics, Inc.股票出现异动，股价急速下挫5.01%。截至发稿，该股报9.91美元/股，成交量7324股，换手率0.15%，振幅3.49%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为5946.82%、1043.39%、585.23%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为181.54%、82.71%、72.79%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242203389681fdaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242203389681fdaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2453795614","title":"Atara Biotherapeutics, Inc.盘中异动 大幅下挫5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453795614","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453795614?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:04","pubTimestamp":1721657070,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时04分，Atara Biotherapeutics, Inc.股票出现波动，股价快速下挫5.45%。截至发稿，该股报10.41美元/股，成交量8774股，换手率0.18%，振幅7.67%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，木薯科学、Mei Pharma, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Mei Pharma, Inc.较为活跃，换手率分别为109.20%、88.43%、26.27%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、木薯科学、Hepion Pharmaceuticals, Inc.，振幅分别为44.07%、29.56%、27.45%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722220430af93730d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722220430af93730d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2452402850","title":"Atara Biotherapeutics, Inc.盘中异动 下午盘大幅上涨5.66%报11.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452402850","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452402850?lang=zh_cn&edition=full","pubTime":"2024-07-20 02:00","pubTimestamp":1721412054,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日02时00分，Atara Biotherapeutics, Inc.股票出现异动，股价快速上涨5.66%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为1689.23%、1587.23%、303.61%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为173.51%、94.92%、82.80%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720020054af933386&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720020054af933386&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2452164698","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.87%报11.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452164698","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452164698?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:54","pubTimestamp":1721231689,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时54分，Atara Biotherapeutics, Inc.股票出现异动，股价快速下挫5.87%。截至发稿，该股报11.55美元/股，成交量5.3138万股，换手率1.08%，振幅7.44%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.65%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3108.93%、1340.12%、286.09%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为76.39%、46.25%、43.75%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717235450af92cd56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717235450af92cd56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2452151825","title":"Atara Biotherapeutics公司——由Bla批准的2000万美元里程碑款项已经触发。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452151825","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452151825?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:00","pubTimestamp":1721221242,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2452824151","title":"Atara Biotherapeutics公司-处方药用户费用法案（Pdufa）的目标行动日期为2025年1月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2452824151","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452824151?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:00","pubTimestamp":1721221217,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2451990948","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.19%报11.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451990948","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451990948?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:32","pubTimestamp":1721136759,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时32分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅拉升5.19%。截至发稿，该股报11.74美元/股，成交量1015股，换手率0.02%，振幅0.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Scisparc Ltd.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1232.35%、516.42%、77.42%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Seres Therapeutics, Inc.、Aeon Biopharma, Inc.，振幅分别为21.25%、21.01%、17.54%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162132409681d2f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162132409681d2f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2451620911","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨7.83%报11.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451620911","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451620911?lang=zh_cn&edition=full","pubTime":"2024-07-16 00:10","pubTimestamp":1721059827,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日00时10分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅拉升7.83%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Artelo Biosciences, Inc.较为活跃，换手率分别为3238.11%、121.45%、116.08%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scinai Immunotherapeutics Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为150.36%、77.09%、74.53%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716001027941f717c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716001027941f717c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2450518365","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450518365","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450518365?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:04","pubTimestamp":1720706647,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时04分，Atara Biotherapeutics, Inc.股票出现波动，股价快速上涨6.32%。截至发稿，该股报9.59美元/股，成交量1.3728万股，换手率0.28%，振幅3.99%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为503.74%、376.07%、274.76%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc，振幅分别为149.00%、82.31%、73.13%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112204079681c05c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112204079681c05c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atarabio.com","stockEarnings":[{"period":"1week","weight":-0.0752},{"period":"1month","weight":-0.4183},{"period":"3month","weight":-0.5403},{"period":"6month","weight":-0.6361},{"period":"1year","weight":-0.8248},{"period":"ytd","weight":-0.4532}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。公司是一个临床阶段的生物制药公司，致力于开发对肌肉萎缩情况和肿瘤学严重的未满足的医疗需求的新疗法。公司的候选产品是针对肌肉生长抑制素和激活素生物制剂，是TGF-β蛋白超家族的成员，它在肌肉和其他许多身体组织的生长和维持中发挥作用。公司的主导候选产品，PINTA745，是在终末期肾病患者的第2阶段临床试验PEW。该公司第二候选产品为STM434，以及该公司预计将在2014年下半年进入STM434的第1阶段临床研究卵巢癌等实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.120552},{"month":2,"riseRate":0.3,"avgChangeRate":-0.046815},{"month":3,"riseRate":0.5,"avgChangeRate":0.062248},{"month":4,"riseRate":0.1,"avgChangeRate":-0.077789},{"month":5,"riseRate":0.4,"avgChangeRate":-0.075569},{"month":6,"riseRate":0.7,"avgChangeRate":0.075872},{"month":7,"riseRate":0.6,"avgChangeRate":-0.046068},{"month":8,"riseRate":0.5,"avgChangeRate":-0.043445},{"month":9,"riseRate":0.666667,"avgChangeRate":0.009953},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.128758},{"month":11,"riseRate":0.8,"avgChangeRate":0.240727},{"month":12,"riseRate":0.2,"avgChangeRate":-0.11122}],"exchange":"NASDAQ","name":"Atara Biotherapeutics","nameEN":"Atara Biotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atara Biotherapeutics,ATRA,Atara Biotherapeutics股票,Atara Biotherapeutics股票老虎,Atara Biotherapeutics股票老虎国际,Atara Biotherapeutics行情,Atara Biotherapeutics股票行情,Atara Biotherapeutics股价,Atara Biotherapeutics股市,Atara Biotherapeutics股票价格,Atara Biotherapeutics股票交易,Atara Biotherapeutics股票购买,Atara Biotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}